Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byThe Medicines Company
Price$240M
Date8/2013

General Information

Offices

HQ
Zernikedreef 9
Leiden, 2333, NLD

Funding

TOTAL $22M
FUNDING TOTAL $22M
Series B, 8/2009
Gilde Healthcare Partners
$11.4M
Series B, 8/2011
Gilde Healthcare Partners
Index Ventures
$10.6M

Tags

ProFibrix

ProFibrix B.V., a biotech company, creates, develops, and markets products for the hemostasis and regenerative medicine markets. Its products include Fibrocaps, a dry powder topical hemostat and tissue sealant based on a mixture of fibrinogen and thrombin, which stops acute and severe bleeding during surgery or in connection with trauma injury. The company also provides a sterilized single-use delivery device to deliver Fibrocaps to the target tissue area without the need to manipulate the wound in a surgical environment. It offers its products based on human fibrinogen, a natural blood protein for haemostasis, blood clotting, and tissue repair and healing. ProFibrix B.V. was founded in 2004

Recent Milestones

Videos

Screenshots

ProFibrix screenshot
Above: ProFibrix Screenshot -- #1
Uploaded: 9/28/09

Sources

  1. Medicines Co. wraps $240M deal to buy ProFibrix following PhIII success Read more: Medicines Co. wraps $240M deal to buy ProFibrix following PhIII success - FierceBiotech http://www.fiercebiotech.com/story/medicines-co-wraps-240m-deal-buy-profibrix-follo (fiercebiotech.com) [edit]
  2. ProFibrix BV receives a $11 million investment (dealipedia.com) [edit]
  3. ProFibrix, B.V.: Series B $10.6M (onbiovc.com) [edit]
Edit This Page
Last Edited 8/6/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy